Release Date: 07/04/10 18:01 Summary: FY2009 Consolidated Group Financial Report and MDA Price Sensitive: Yes Download Document 744.54KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%